Neonatal point-of-care testing market seen reaching $2.59 billion by 2030

The neonatal point-of-care testing market is projected to rise from $1.52 billion in 2026 to $2.59 billion by 2030, driven by demand for faster newborn diagnostics, remote monitoring and portable testing tools. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Neonatal point-of-care testing gives clinicians rapid diagnostic results at the newborn’s bedside. - Faster testing can shorten treatment delays and reduce reliance on centralized labs. - The market is growing as hospitals, clinics and health systems push for quicker newborn care and better monitoring.

What happened: - The Business Research Company said the neonatal point-of-care testing market will grow from $1.32 billion in 2025 to $1.52 billion in 2026. - The market is projected to reach $2.59 billion by 2030. - The forecast implies a 14.5% CAGR from 2025 to 2026 and 14.3% CAGR from 2026 to 2030. - The company released the market outlook from London on Aug. 19, 2026. - The company also offered a free sample of the report and the full market report.

The details: - The market’s recent growth has been driven by heightened awareness of neonatal mortality. - Adoption of rapid testing devices in medical facilities has increased. - Government support for neonatal healthcare has also helped expansion. - Maternity clinic growth and bedside testing advances are additional contributors. - The market’s next phase is expected to benefit from AI-powered diagnostic tools. - Cloud technologies for neonatal data management are another growth factor. - Portable and compact point-of-care devices are gaining traction. - Private-public collaboration in newborn health is expected to expand. - Neonatal healthcare infrastructure is growing, especially in emerging economies. - Emerging trends include AI-enabled neonatal diagnostics, cloud-based testing platforms, real-time data analytics, portable devices and IoT-based continuous newborn monitoring.

Between the lines: - Remote patient monitoring is a major demand driver because it extends care beyond centralized facilities. - Neonatal point-of-care testing fits that model by delivering immediate results without sending samples to a distant lab. - Vivalink reported in August 2023 that 84% of current remote patient monitoring users planned to expand usage in 2024. - Vivalink also found that 45% of healthcare professionals use remote monitoring for acute care in hospital-at-home programs. - The same survey found 77% expect RPM-based care to surpass traditional inpatient hospital care within five years. - North America held the largest market share in 2025 because of stronger healthcare infrastructure and technology adoption. - Asia-Pacific is expected to post the fastest growth rate as health systems expand and investment in neonatal care rises. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and trend analysis.

What's next: - Market growth is likely to center on AI-enabled diagnostics and connected devices. - Providers and device makers will likely focus on portable systems that can support bedside and remote newborn care. - Expanding neonatal infrastructure in emerging markets could shape where the fastest gains happen through 2030.

The bottom line: - Neonatal point-of-care testing is moving from niche convenience to core newborn-care infrastructure, with growth tied to speed, connectivity and broader access to diagnostic services.